These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9785061)

  • 21. Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
    Rizos E; Mikhailidis DP
    Cardiovasc Res; 2001 Nov; 52(2):199-207. PubMed ID: 11684067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of low HDL-cholesterol levels in the reduction of cardiovascular risk].
    Stokić E; Marinkov J
    Med Pregl; 2007; 60(3-4):145-50. PubMed ID: 17853726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
    Boden WE; Pearson TA
    Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current thinking in lipid lowering.
    Ballantyne CM
    Am J Med; 1998 Jun; 104(6A):33S-41S. PubMed ID: 9684850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.
    Boden WE
    Am J Cardiol; 2000 Dec; 86(12A):19L-22L. PubMed ID: 11374850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions.
    Barter P; Kastelein J; Nunn A; Hobbs R;
    Atherosclerosis; 2003 Jun; 168(2):195-211. PubMed ID: 12801602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond LDL-C--the importance of raising HDL-C.
    Wierzbicki AS; Mikhailidis DP
    Curr Med Res Opin; 2002; 18(1):36-44. PubMed ID: 11999145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting high-density lipoproteins: update on a promising therapy.
    Verdier C; Martinez LO; Ferrières J; Elbaz M; Genoux A; Perret B
    Arch Cardiovasc Dis; 2013 Nov; 106(11):601-11. PubMed ID: 24074699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease.
    Hay JW; Sterling KL
    Pharmacoeconomics; 2005; 23(2):133-41. PubMed ID: 15748088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.
    Manninen V; Elo MO; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    JAMA; 1988 Aug; 260(5):641-51. PubMed ID: 3164788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focus on high-density lipoproteins in reducing cardiovascular risk.
    Brewer HB
    Am Heart J; 2004 Jul; 148(1 Suppl):S14-8. PubMed ID: 15211328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The triglyceride-high-density lipoprotein axis: an important target of therapy?
    Szapary PO; Rader DJ
    Am Heart J; 2004 Aug; 148(2):211-21. PubMed ID: 15308990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of coronary heart disease: the role of high density lipoproteins.
    Miller NE
    Postgrad Med J; 1980 Aug; 56(658):575-8. PubMed ID: 7465461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events.
    Whitney EJ; Krasuski RA; Personius BE; Michalek JE; Maranian AM; Kolasa MW; Monick E; Brown BG; Gotto AM
    Ann Intern Med; 2005 Jan; 142(2):95-104. PubMed ID: 15657157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDL and triglyceride as therapeutic targets.
    Fruchart JC; Duriez P
    Curr Opin Lipidol; 2002 Dec; 13(6):605-16. PubMed ID: 12441884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary heart disease, cancer, lipoproteins, and the effects of clofibrate: is enzyme induction a common link and are lipoproteins red herrings?
    Heller RF
    Lancet; 1981 Dec; 2(8258):1258-60. PubMed ID: 6118672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of serum high density lipoproteins.
    Frohlich JJ; Pritchard PH
    Clin Biochem; 1989 Dec; 22(6):417-23. PubMed ID: 2692872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.